Kaposi's sarcoma associated herpesvirus (KSHV), like other human herpes viruses,
establishes a biphasic life cycle referred to as dormant or latent, and productive or lytic …

Angiosarcoma, epithelioid hemangioendothelioma, and Kaposi sarcoma are classified
according to the line of differentiation that these neoplastic cells most closely resemble: the …

The latency-associated nuclear antigen (LANA) of Kaposi sarcoma herpesvirus (KSHV) is
mainly localized and functions in the nucleus of latently infected cells, playing a pivotal role …

Kaposi's sarcoma-associated herpesvirus (KSHV), also known as Human herpesvirus 8
(HHV-8), is a member of the lymphotropic gammaherpesvirus subfamily and a human …

The transcriptomic analysis of microarray and RNA-Seq datasets followed our own
bioinformatic pipeline to identify a transcriptional regulatory network of lung cancer. Twenty …

Kaposi sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8, is an oncogenic
herpesvirus. Its latency-associated nuclear antigen (LANA) is essential for the persistence of …

Toll-like receptors (TLR) are conserved immune sensors mediating antimicrobial and
antitumoral responses, but recent evidence implicates them in promoting carcinogenesis in …

Hepatitis B, which caused by hepatitis B virus (HBV) infection, remains a major health threat
worldwide. Hepatic injury and regeneration from chronic inflammation are the main driving …

Discovered in 1994, Kaposi's sarcoma-associated herpesvirus (KSHV) has been associated
with four human malignancies including Kaposi's sarcoma, primary effusion lymphoma, a …

The immediate early viral protein replication and transcription activator (RTA) of Kaposi's
sarcoma-associated herpesvirus (KSHV) is essential for activating the lytic cycle of KSHV …